Brief: Lombard Medical presents data from 3-year follow up of U.S. PYTHAGORAS pre-marketing approval trial of Aorfix

Lombard Medical

30/11/2015 11:00

Nov 30 (Reuters) - Lombard Medical Inc  EVAR.O : 
 * Presented efficacy and safety data from the three-year follow up of the U.S. 
   PYTHAGORAS pre-marketing approval trial of Aorfix 
 * Data showed 100% freedom from Type I & III endoleaks, 92.9% freedom from 
   aneurysm sac expansion, 92.9% freedom from device migration 
 * Anticipates publication of the five-year outcomes in 2016 
 
 * Source text for Eikon  ID:nGNXVEWRHa  
 
 * Further company coverage  EVAR.O  ((Bengaluru Newsroom; +1 646 223 8780))